Example: air traffic controller
Search results with tag "Annex i"
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.euLENVIMA as monotherapy is indicated for the treatment of adult patients with progressive, locally advanced or metastatic, differentiated (papillary/follicular/Hürthle cell) thyroid carcinoma (DTC), refractory to radioactive iodine (RAI).
Annex I – Scope of accreditation - FSSC 22000
www.fssc22000.comPart V - Annex I: Scope of accreditation Version 4.1 – July 2017 1 of 2 Annex I – Scope of accreditation The scope of accreditation is given below: